Repurposing FDA-approved drugs to find a novel inhibitor of alpha-ketoglutarate-dependent dioxygenase FTO to treat esophageal cancer
Authors
- Jahanbakhsh Asadi (ORCID: https://orcid.org/0000-0002-7068-2970)
- Seyyed Mehdi Jafari (ORCID: https://orcid.org/0000-0003-0483-7505)
- Zeinab Mohammadi (ORCID: https://orcid.org/0000-0001-5043-3275)
- Marie Saghaeian Jazi (ORCID: https://orcid.org/0000-0003-0647-9545)
- Massoud Amanlou
- Seyyed Mostafa Mir
Institutions
- Golestan University (IR)
- Golestan University of Medical Sciences (IR)
- Tehran University of Medical Sciences (IR)
Publication Details
- Journal
- Research in Pharmaceutical Sciences
- Published
- 2025-05-01
- DOI
- https://doi.org/10.4103/rps.rps_9_25
- Primary Topic
- RNA modifications and cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00